AKT1 and Insulin resistance: They also demonstrated that AME increases phosphoinositide 3-kinase (PI3K) protein expression, which may improve insulin signal transduction disorders through the PI3K/protein kinase B (Akt) signaling pathway, thereby alleviating insulin resistance (Ke et al., 2013).